Patents Examined by Paul Dickinson
-
Patent number: 10653713Abstract: Broad cerebrospinal fluid (CSF) distribution of an agent is achievable by delivering the agent in a liquid formulation to the CSF at flow rates less than 500 microliters per hour, such as between about 2 microliters per hour and about 100 microliters per hour.Type: GrantFiled: October 6, 2011Date of Patent: May 19, 2020Assignee: Medtronic, Inc.Inventors: Deepak Ramesh Thakker, Lisa L. Shafer, Greg Stewart
-
Patent number: 9994733Abstract: The invention relates to a method for coating surfaces by enzymatic reaction of a biopolymer, wherein the method comprises the following steps: a) applying an enzyme to the surface of a substrate, and b) contacting the enzyme with the biopolymer to be deposited, wherein the enzyme cleaves the biopolymer, wherein the cleavage gives rise to at least two cleavage products of the biopolymer having different solubility in a solvent, and at least one cleavage product of the biopolymer having relatively low solubility is deposited on the surface of the substrate, and to a coated article obtainable by the method and to a coating composition comprising a biopolymer and at least one component selected from the group comprising binders, fillers, pigments and/or additives, and optionally a solvent.Type: GrantFiled: March 31, 2015Date of Patent: June 12, 2018Assignee: Universität PaderbornInventors: Oliver Ingolf Strube, Wolfgang Bremser, Arne Alexander Rüdiger
-
Patent number: 9925212Abstract: The present invention generally relates to methods of treating hypertension (HTN) in patients in need thereof wherein the patient optionally further suffers from chronic kidney disease (CKD) or Type II diabetes mellitus (T2DM). The invention also relates to methods of treating hyperkalemia in a patient in need thereof, wherein the patient suffers from CKD, T2DM or HTN and are optionally being treated with an effective amount of a renin-angiotensin-aldosterone system (RAAS) agent. The invention also relates to methods of treating kidney disease in a patient in need thereof, wherein the patient is optionally being treated with an effective amount of a renin-angiotensin-aldosterone system (RAAS) agent. The methods can comprise administering an effective amount of a potassium-binding agent to the patient to lower the patient's blood pressure and/or increase or stabilize the patient's kidney function.Type: GrantFiled: October 6, 2016Date of Patent: March 27, 2018Assignee: Relypsa, Inc.Inventors: Gerrit Klaerner, Lance Berman
-
Patent number: 9913911Abstract: Carrier nanoparticles comprising a polymer containing a polyol coupled to a polymer containing a boronic acid and a linkage cleavable under reducing conditions, configured to present the polymer containing a boronic acid to an environment external to the nanoparticle and related compositions, methods and systems.Type: GrantFiled: December 7, 2016Date of Patent: March 13, 2018Assignee: California Institute of TechnologyInventors: Mark E. Davis, Akinleye Alabi
-
Patent number: 9910037Abstract: The present disclosure relates to compositions, methods, and kits for the rapid detection, separation and/or isolation of microorganisms. Specifically, the disclosure relates to compositions, methods, and kits for using vancomycin—PVA backbone complexes to capture and/or concentrate microorganisms in an aqueous sample, such as gram positive and/or gram negative bacteria in solution.Type: GrantFiled: March 13, 2014Date of Patent: March 6, 2018Assignee: Iris International, Inc.Inventors: Edward Jablonski, Carl Hulle
-
Patent number: 9903797Abstract: An object of the present invention is to provide: a staining agent for tissue staining which has an improved fluorescence signal evaluation accuracy; and a tissue staining kit comprising the staining agent. The staining agent for tissue staining contains, as a staining component, dye-resin particles comprising thermosetting resin particles and a fluorescent dye immobilized on the resin particles, wherein the resin particles contains a substituent having an electric charge opposite to that of the fluorescent dye and forms an ionic bond or a covalent bond with the fluorescent dye, and the dye-resin particles have a particle size variation coefficient of 15% or less.Type: GrantFiled: March 6, 2014Date of Patent: February 27, 2018Assignee: KONICA MINOLTA, INC.Inventors: Kensaku Takanashi, Yasushi Nakano, Takeshi Isoda, Hideki Gouda
-
Patent number: 9895315Abstract: The tablets, compositions and methods of the present invention, comprising a carbonate salt of an aliphatic amine polymer and s monovalent anion can prevent or ameliorate acidosis, in particular acidosis in patients with renal disease. The tablets and compositions of the present invention maintain a disintegration time of no greater than 30 minutes at 37° C. and at pH of at least 1 for a period of at least ten weeks at 60° C. Furthermore, the tablets are stable for extended periods of time without the need for specialized storage conditions.Type: GrantFiled: December 14, 2016Date of Patent: February 20, 2018Assignee: Genzyme CorporationInventors: Hitesh R. Bhagat, Jeffrey M. Goldberg, Abizer I. Harianawala, Louis Brenner
-
Patent number: 9895470Abstract: Substrates, optionally coated with an undercoating layer, having grafted there from one or more non-fouling materials are described herein. The non-fouling, polymeric material can be grafted from a variety of substrate materials, particularly polymeric substrates and/or polymeric undercoating layers. The graft-from techniques described herein can result in higher surface densities of the non-fouling material relative to graft-to formulations. Graft-from methods can be used to produce covalently tethered polymers. The compositions described herein are highly resistant protein absorption, particularly in complex media and retain a high degree of non-fouling activity over long periods of time. The compositions described herein may also demonstrate antimicrobial and/or anti-thrombogenic activity.Type: GrantFiled: December 7, 2009Date of Patent: February 20, 2018Assignee: Semprus Biosciences Corp.Inventors: Jun Li, Trevor Squier, Zheng Zhang, Chad Huval, William Shannan O'Shaughnessy, Michael Hencke, Michael Bouchard, Christopher R. Loose
-
Patent number: 9884880Abstract: The present invention provides novel bisphosphonates vinylic monomers, polymers and particles that have utility as biologically active molecule (such as drugs) carriers, medical device coatings and for imaging/radiology applications, especially in bone and dental applications. The invention also provides methods of synthesizing the monomers, polymerizing the polymers, and assembling the particles of the invention.Type: GrantFiled: May 20, 2013Date of Patent: February 6, 2018Assignee: Bar-Ilan UniversityInventors: Shlomo Margel, Dana Mizrahi, Eran Gluz, Ravit Chen
-
Patent number: 9884021Abstract: A tablet comprising a core containing an active agent, and a coating, the core being disposed within the coating such that the coating has a thickness about a longitudinal axis (X-Y) of about 4.85 to 4.95 mm. The position of the core within the coating dictating that the active agent is released rapidly after a lag time during which time no active agent is released.Type: GrantFiled: October 7, 2015Date of Patent: February 6, 2018Assignee: Jagotec AGInventors: Guy Vergnault, Pascal Grenier, Christophe Dragan
-
Patent number: 9878506Abstract: Method for making a tough and compliant hydrogel. A precursor hydrogel is made of a first polymer selected to maintain high elasticity and a second polymer selected to dissipate mechanical energy. The precursor hydrogel is stretched to a multiple of its original length to form a pre-stretched hydrogel. The pre-stretched hydrogel is allowed to relax and is soaked in a biocompatible solvent to reach equilibrium swelling of the pre-stretched hydrogel whereby shear modulus of the hydrogel is reduced.Type: GrantFiled: December 16, 2015Date of Patent: January 30, 2018Assignee: Massachusetts Institute of TechnologyInventors: Xuanhe Zhao, Shaoting Lin, Hyunwoo Yuk
-
Patent number: 9872926Abstract: The present invention relates to pH-tunable, highly activatable multicolored fluorescent nanoplatforms and methods of using the nanoplatforms in a variety of applications including, but not limited to, investigating fundamental cell physiological processes such as pH regulation in endocytic vesicles, endosome/lysosome maturation, and effect of pH on receptor cycling and trafficking of subcellular organelles.Type: GrantFiled: October 19, 2016Date of Patent: January 23, 2018Assignee: The Board of Regents of the University of Texas SystemInventors: Jinming Gao, Kejin Zhou, Baran D. Sumer
-
Patent number: 9872881Abstract: Bone- and metal-targeted polymeric nanoparticles are provided. Exemplary nanoparticles have three main components: 1) a targeting element that can selectively bind to bone, minerals, or metal ions; 2) a layer of stealth to allow the polymer to evade immune response; and 3) a biodegradable polymeric material, forming an inner core which can carry therapeutics or other diagnostics. Preferred nanoparticles contain a blend of target-element polymer conjugate and polymer that optimizes the ligand density on the surface of the nanoparticle to provide improved targeting of the nanoparticle. The ratio of target-element polymer conjugate to polymer can also be optimized to improve the half-life of the nanoparticles in the blood of the subject. The nanoparticles also exhibit prolonged, sustained release of therapeutic agents loaded into the particles.Type: GrantFiled: November 3, 2014Date of Patent: January 23, 2018Assignees: The Brigham and Women's Hospital, Inc., Massachusetts Institute of TechnologyInventors: Archana Swami, Pamela Basto, Jeffrey Karp, Omid C. Farokhzad
-
Patent number: 9867883Abstract: Isatoic anhydride derivatives having an N-substituent which includes a quaternary ammonium group are useful for labeling and/or functionalizing a target material and/or for coupling materials together. The isatoic anhydride derivatives of the present disclosure can be advantageously water soluble, easily prepared and purified. Isatoic anhydride derivatives useful in the present disclosure preferably have at least one chemically reactive group or at least one binding group or at least one detectable label. Anthranilate derivatives made from the isatoic anhydrides derivatives or otherwise and kits including the isatoic anhydride derivatives are also disclosed.Type: GrantFiled: October 21, 2016Date of Patent: January 16, 2018Assignee: The University of North Carolina at CharlotteInventors: Craig A. Ogle, Anthony J. Fowler
-
Patent number: 9861701Abstract: Fragmented polysaccharide based hydrogel compositions and methods of making and using the same are provided. The subject polysaccharide based hydrogel compositions are prepared by combining a polysaccharide component with a hydrophilic polymer and a cross-linking agent. Also provided are kits and systems for use in preparing the subject compositions.Type: GrantFiled: January 31, 2017Date of Patent: January 9, 2018Assignee: SpotLight Technology Partners LLCInventors: Scott Robert Sershen, Suresh Subraya Pai, Glen Gong
-
Patent number: 9855278Abstract: Controlled-release preparations of oxcarbazepine and derivatives thereof for once-a-day administration are disclosed. The inventive compositions comprise solubility- and/or release enhancing agents to provide tailored drug release profiles, preferably sigmoidal release profiles. Methods of treatment comprising the inventive compositions are also disclosed.Type: GrantFiled: May 27, 2016Date of Patent: January 2, 2018Assignee: Supernus Pharmaceuticals, Inc.Inventors: Padmanabh P. Bhatt, Argaw Kidane, Kevin Edwards
-
Patent number: 9849197Abstract: [Problem] To provide a novel fluorescent nanoparticle imaging probe having a switching function (a function to quench a fluorescent dye in a blood component and emit fluorescence in a tumor or an inflamed site to be imaged).Type: GrantFiled: March 1, 2012Date of Patent: December 26, 2017Assignees: KYOTO UNIVERSITY, SHIMADZU CORPORATIONInventors: Hideo Saji, Shunsaku Kimura, Masahiro Ono, Takashi Temma, Isao Hara, Eiichi Ozeki
-
Patent number: 9844597Abstract: The present invention provides compositions, and related kits and methods, for formation of hydrogels. The compositions comprise one or more chemically crosslinkable agents dissolved in an aqueous solution to form a precursor solution. The chemically crosslinkable agents useful in the present invention are selected from polymers modified with a molecule selected from acrylate, maleimide, vinylsulfone, N-hydroxysuccinimide, aldehyde, ketone, carbodiimide, carbonate, iodoacetyl, mercaptonicotinamide, quinone, thiol, amine, and combinations thereof. The precursor solution is characterized as being in an aqueous form at a non-physiologic physical-chemical condition and undergoing gelation when in contact with another fluid or body at a physiologic physical-chemical condition.Type: GrantFiled: April 17, 2014Date of Patent: December 19, 2017Assignee: THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGYInventors: Ying Chau, Yu Yu, Jieying Zhong
-
Patent number: 9839717Abstract: The present invention provides a method for making an adhesive composition. An adhesive substrate comprising at least a first cyanoacrylate monomer is provided and then mixed with a thickening agent containing polycyanoacrylate prepared by polymerization of a second cyanoacrylate monomer initiated with an aqueous solution of ammonium hydroxide or alcohol. In light of low boiling point of ammonium hydroxide and alcohol, they can be easily removed by heating at low temperature. As such, conventional premature polymerization of adhesive substrate owing to addition of a thickening agent containing residual accelerators can be overall improved.Type: GrantFiled: September 10, 2015Date of Patent: December 12, 2017Inventor: Fa-Ter Chu
-
Patent number: 9839700Abstract: The invention relates to polymerized micelles of size inferior to 100 nm for in vivo diagnosis, in particular of cancer. The polymerized micelles of the invention comprise a diagnostic agent and an amphiphilic polymer obtainable by the polymerization of an amphiphilic monomer, said monomer comprising: a lipophilic chain comprising a polymerizable vinylic or diacetylenic group, and a hydrophilic head comprising a polyoxyethylene or polyoxypropylene chain. The invention finds application in the pharmaceutical field, in particular.Type: GrantFiled: July 7, 2011Date of Patent: December 12, 2017Assignee: COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVESInventors: Eric Doris, Frédéric Duconge, Edmond Gravel, Nicolas Mackiewicz, Bertrand Tavitian